Tag:

Merck

COVID-19: Stop & Shop Pharmacies Now Offering Anti-Viral Medication COVID-19: Stop & Shop Pharmacies Now Offering Anti-Viral Medication
Covid-19: Stop & Shop Pharmacies Now Offering Anti-Viral Medication Stop & Shop has begun offering two approved COVID-19 antiviral medicines, Pfizer's Paxlovid and Merck's Molnupiravir at its 55 New York pharmacies. The mega-supermarket chain made the announcement on Thursday, April 7, that the drugs would be available at no cost with a valid prescription from a health care provider. The COVID-19 anti-viral medication Molnupiravir can be prescribed to those 18 and older, while Paxlovid is authorized for use by adults and children ages 12 and older weighing at least 88 pounds, store officials said. Availability of the anti-viral oral prescript…
CHILLING AUDIO: Local NJ Police Try To Convince Man To Drop Sword Before Shooting Him CHILLING AUDIO: Local NJ Police Try To Convince Man To Drop Sword Before Shooting Him
Chilling Audio: Local NJ Police Try To Convince Man To Drop Sword Before Shooting Him "Patrick, drop it," a New Jersey police officer says in a calm, steady voice, pleading several times with a man wielding a 3-foot sword to surrender. "Listen to me, I know you're going through some...," the officer says before his voice rises. "Patrick drop it! Get on the ground! Get on the ground!" he screams. "Drop the knife!" Then four shots are heard. The confrontation in Somerset County early last fall lasted barely a minute. About an hour and 20 minutes later, Patrick Chin, 43, was pronounced dead at Robert Wood Johnson University Hospital in New Brunswick. The comman…
COVID-19: FDA Authorizes Second Antiviral Pill COVID-19: FDA Authorizes Second Antiviral Pill
Covid-19: FDA Authorizes Second Antiviral Pill For the second time in as many days, the Food and Drug Administration (FDA) has authorized the use of an antiviral pill to treat mild and moderate COVID-19 cases. On Thursday, Dec. 23, the FDA approved the use of Merck’s molnupiravir pill for emergency use authorization, a day after officials authorized the use of Pfizer’s COVID-19 treatment pill. Earlier story - COVID-19: FDA OKs First Authorized Home Treatment For Virus Merck’s pill has been cleared for use by adults 18 and older who have tested positive for COVID-19 and are at the greatest risk of being hospitalized or dying from t…
COVID-19: FDA OKs First Authorized Home Treatment For Virus COVID-19: FDA OKs First Authorized Home Treatment For Virus
Covid-19: FDA OKs First Authorized Home Treatment For Virus The fight against COVID-19 took a step forward as federal health officials authorized the first pill that Americans will be able to take at home to head off the worst effects of the virus. On Wednesday, Dec. 22, the US Food and Drug Administration (FDA) granted emergency authorization for Pfizer’s COVID-19 treatment pill, which has been recommended for people at high risk of developing severe cases of COVID-19. The pill could be available as soon as this weekend, according to Pfizer CEO Albert Bourla. Related story - COVID-19: Pfizer Releases Data On Anti-Viral Pill's Effective…
AG: Hillsborough Man Wielded 3-Foot-Long Sword Before Being Pepper-Sprayed, Shot By Police AG: Hillsborough Man Wielded 3-Foot-Long Sword Before Being Pepper-Sprayed, Shot By Police
AG: Hillsborough Man Wielded 3-Foot-Long Sword Before Being Pepper-Sprayed, Shot By Police A Hillsborough man was holding a three-foot-long sword when he was pepper-sprayed and then shot and killed by police at his home last month, New Jersey's top law enforcement official said Monday. Five uniformed Hillsborough officers responding to a request for a welfare check went to the Piedmont Path home where Patrick Chin, 43, and his new bride lived at 4:10 p.m. Sept. 28, Acting Attorney General Andrew J. Bruck said. "When the officers arrived, they encountered Mr. Chin inside the home holding an approximately three-foot long sword," Bruck said. "During the encounter, Officer George …
COVID-19: Drugmaker To Seek Emergency Approval For Pill To Treat Virus COVID-19: Drugmaker To Seek Emergency Approval For Pill To Treat Virus
Covid-19: Drugmaker To Seek Emergency Approval For Pill To Treat Virus A new pharmaceutical company is throwing its hat in the ring as the country continues its fight against COVID-19. Merck and Ridgeback Biotherapeutics announced on Friday, Oct. 1 that it is planning to apply for federal emergency approval of a pill that can reportedly help prevent hospitalizations and deaths in COVID-19 patients. According to the company, trials have found that the pill - dubbed molnupiravir - could potentially reduce the risk of hospitalization or death in patients with mild to moderate COVID-19 by approximately 50 percent. The results of the late-stage trial have bee…
COVID-19: Little Brown Pill Could Be Difference Maker In Fight Against Virus COVID-19: Little Brown Pill Could Be Difference Maker In Fight Against Virus
Covid-19: Little Brown Pill Could Be Difference Maker In Fight Against Virus Scientists may have cracked the code to help in the fight against COVID-19 and potential future pandemics. Though still in clinical trials, the “little brown pill” molnupiravir may give doctors and researchers a new tool and treatment as the country continues combating the latest wave of COVID-19 cases. Merck (also known as MSD), and Ridgeback Biotherapeutics, LP announced earlier this month that they ran a randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability, and efficacy of the pill to eliminate the strain that causes COVID-19. According to the prelimin…
COVID-19: NJ Drug Manufacturer Merck Says New Antiviral Drug Shows Quick Reduction In Virus COVID-19: NJ Drug Manufacturer Merck Says New Antiviral Drug Shows Quick Reduction In Virus
Covid-19: NJ Drug Manufacturer Merck Says New Antiviral Drug Shows Quick Reduction In Virus Experimental antiviral drug molnupiravir being developed by New Jersey drug manufacturer Merck with Ridgeback Bio shows a quick reduction of the infectious virus in a study among participants with early COVID-19. Molnupiravir is being tested in a Phase 2/3 trial set to be completed in May. Merck will be provided with up to  $268.8 million in funding from the Biomedical Advanced Research and Development Authority within the U.S. Department of Health and Human Services. Associate Professor of Medicine at the University of North Carolina School of Medicine William Fis…
Through Her Lens, Westport Native Lynsey Addario Tells The Stories We Need To Know Through Her Lens, Westport Native Lynsey Addario Tells The Stories We Need To Know
Through Her Lens, Westport Native Lynsey Addario Tells The Stories We Need To Know Perhaps it’s because Lynsey Addario grew up the youngest of four sisters. Perhaps it’s because she was raised to be nonjudgmental and encouraged to be open and accepting by her hairdresser parents. Or, perhaps, it’s because she cares about capturing entire stories through her photographs, bearing witness to things that others may turn away from. Actually, it’s all this and more that has made Addario an Emmy Award -- and Pulitzer Prize -- winning photojournalist as well as MacArthur Grant recipient who’s work regularly appears in the New York Times, National Geographic, Time magazine and oth…
U.S. News Ranks New Jersey 12th Best State U.S. News Ranks New Jersey 12th Best State
U.S. News Ranks New Jersey 12th Best State In our hearts, New Jersey might be the best state but according to U.S. News, there are 11 others ahead of us. The Garden State shines for its education, health care, opportunity and crime/corrections, according to the website's annual report.  New Jerseyans earn a median income of $40,567 and 46 percent of residents are college-educated. The state was ranked at No. 49 for fiscal stability (yikes), Illinois at 50. Washington holds the top seed for its infrastructure, economy, healthcare and education with New Hampshire in second -- ranked No. 1 for crime/corrections and opportunity. …